DM Clinical Research is celebrating its 20th anniversary, marking two decades of expanding access to clinical trials and helping accelerate the development of innovative therapies for patients across the United States. Founded in 2006 with a vision to make clinical research more accessible and patient-centered, the organization has grown into one of the nation's leading integrated clinical research networks, with a footprint that now includes more than 35 research sites and access to a patient population of 1.97 million individuals across 32 therapeutic areas.
The company's founder and CEO, Mohammad Millwala, reflected on the milestone: "Reaching 20 years is incredibly meaningful to me. When I think about DM Clinical Research, I think first about the people, the employees who have poured their talent and heart into this organization, and the patients who have trusted us to be part of their healthcare journey. We've experienced so much growth and change over the past two decades, but what has never changed is our commitment to our patients and to doing meaningful work that makes a difference. I'm incredibly proud of what we've built together, and I'm even more excited about what we can accomplish in the next 20 years."
Over the past two decades, DM Clinical Research has enrolled more than 35,000 patients in clinical trials, contributing to the advancement of safe, life-changing therapies. The organization partners with leading pharmaceutical, biotechnology, and healthcare organizations, as well as contract research organizations (CROs), to conduct high-quality trials. Its integrated operating model combines local physician relationships and patient access with centralized infrastructure, delivering strong enrollment performance, diverse patient access, and operational excellence. This approach has been recognized through industry honors, including the SPRIA Award for vaccine enrollment, the Excellence in Patient Centricity Award, ViE's Best Clinical Trial Network Award, and the SCRS Site Spark Award. In 2025, Millwala was honored with the SCRS Christine K. Pierre Site Impact Award for his leadership.
The company's 20th anniversary theme, "Champions of Clinical Research: 20 Years of Impact," reflects the teamwork, innovation, and dedication that have fueled its growth. Guided by core values—Think Forward, Find a Way, Create Impact, Own It, and Win Together—DM Clinical continues to invest in its people and expand access to research, particularly in underserved communities. As Millwala noted, "The next chapter for DM Clinical is about expanding access to research, embracing new technologies, and ensuring more patients have the opportunity to participate in clinical trials that can change lives."
As DM Clinical enters its third decade, it plans continued expansion into new communities, broader therapeutic expertise, and increased investment in innovative technologies to improve patient access to clinical research. This anniversary underscores the importance of the company's mission: to accelerate the development of tomorrow's treatments by connecting patients with trusted physicians and high-quality clinical trials.
